| Product Code: ETC7648293 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Coagulation Factor VII Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Coagulation Factor VII Treatment Market - Industry Life Cycle |
3.4 Israel Coagulation Factor VII Treatment Market - Porter's Five Forces |
3.5 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.9 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.10 Israel Coagulation Factor VII Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Israel Coagulation Factor VII Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hemophilia and other bleeding disorders in Israel |
4.2.2 Growing awareness about the benefits of coagulation factor VII treatment |
4.2.3 Technological advancements leading to the development of improved treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with coagulation factor VII treatment |
4.3.2 Limited reimbursement policies for such treatments in Israel |
4.3.3 Potential side effects and risks associated with the use of coagulation factor VII products |
5 Israel Coagulation Factor VII Treatment Market Trends |
6 Israel Coagulation Factor VII Treatment Market, By Types |
6.1 Israel Coagulation Factor VII Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Inherited factor VII deficiency, 2021- 2031F |
6.1.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Non-inherited factor VII deficiency, 2021- 2031F |
6.2 Israel Coagulation Factor VII Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Recombinant Factor VIIa, 2021- 2031F |
6.2.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Fresh Frozen Plasma, 2021- 2031F |
6.2.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Cryoprecipitate, 2021- 2031F |
6.2.5 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Prothrombin Complex Concentrates, 2021- 2031F |
6.2.6 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Antifibrinolytic Agents, 2021- 2031F |
6.2.7 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Coagulation Factor VII Treatment Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Clotting Tests, 2021- 2031F |
6.3.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Factor Assays, 2021- 2031F |
6.3.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Prenatal Diagnosis, 2021- 2031F |
6.3.5 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Coagulation Factor VII Treatment Market, By Symptoms |
6.4.1 Overview and Analysis |
6.4.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Bleeding in soft tissues and muscles, 2021- 2031F |
6.4.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Frequent bruising, 2021- 2031F |
6.4.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Bleeding in the spaces of joints, 2021- 2031F |
6.4.5 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Excessive bleeding from injuries or surgical wounds, 2021- 2031F |
6.4.6 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Bleeding in the skull, 2021- 2031F |
6.4.7 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Bleeding in the gut, 2021- 2031F |
6.5 Israel Coagulation Factor VII Treatment Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Tablet, 2021- 2031F |
6.5.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Injection, 2021- 2031F |
6.5.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Coagulation Factor VII Treatment Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.6.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Israel Coagulation Factor VII Treatment Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Clinic, 2021- 2031F |
6.8.3 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By Hospital, 2021- 2031F |
6.8.4 Israel Coagulation Factor VII Treatment Market Revenues & Volume, By , 2021- 2031F |
7 Israel Coagulation Factor VII Treatment Market Import-Export Trade Statistics |
7.1 Israel Coagulation Factor VII Treatment Market Export to Major Countries |
7.2 Israel Coagulation Factor VII Treatment Market Imports from Major Countries |
8 Israel Coagulation Factor VII Treatment Market Key Performance Indicators |
8.1 Patient adherence rate to coagulation factor VII treatment |
8.2 Number of clinical trials and research studies conducted in Israel for advancing coagulation factor VII treatments |
8.3 Rate of adoption of new coagulation factor VII products in the market |
9 Israel Coagulation Factor VII Treatment Market - Opportunity Assessment |
9.1 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.5 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.6 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Israel Coagulation Factor VII Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Coagulation Factor VII Treatment Market - Competitive Landscape |
10.1 Israel Coagulation Factor VII Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Coagulation Factor VII Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here